Suven Pharmaceuticals Limited (SPL) announced the acquisition of 100 per cent stake in Caper Pharma Pvt. Ltd. (CPPL) for about Rs 155 crores. Post acquisition, Caper Pharma will become a wholly-owned subsidiary of Suven Pharmaceuticals. According to the company’s exchange filing, “we wish to inform you that the Board of Directors of Suven Pharmaceuticals Limited…